Science news articles about 'monoclonal antibodies'

... in development and use of monoclonal antibodies. "Treatment modifications might be able ... presence of these receptor proteins. Monoclonal antibodies already offer effective treatment for ...

... surgery. "The use of monoclonal antibodies is rising for a ... II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. ... The use of two different monoclonal antibodies, CDA1 and CDB1, administered ...

Human monoclonal antibodies (mAbs)--highly specific ... technique for making human monoclonal antibodies efficiently and quickly, Drs ... now rapidly generate human monoclonal antibodies that potentially could ...

Monoclonal antibodies directed against tumor ... Despite the increasing use of monoclonal antibody therapy, it is not ... tumor cell removal following monoclonal antibody treatment by actively phagocytosing ...

The strategy of using monoclonal antibodies for cancer treatment was first ... . For several types of cancer, monoclonal antibodies have already offered this advantage ...

... efficacy and safety of the monoclonal antibody, dupilumab, in patients with "persistent ... asthma. Dupilumab, a fully human monoclonal antibody discovered by Regeneron Pharmaceuticals and ...

... measure the structural configuration of monoclonal antibodies (mAbs), an important factor in ... of these biomolecules as medicines. Monoclonal antibodies are proteins manufactured in the ...

New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today.

Monoclonal antibodies are the largest class of ...

Monoclonal antibodies are manufactured in the laboratory and then cloned to attach to specific disease cells without injuring healthy tissue.

Scientists have created a unique monoclonal antibody that can effectively reach inside a cancer cell.

Researchers have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

A monoclonal antibody targeting a protein known as SFPR2 has been shown to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.

Researchers have provided the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research could one day lead to effective therapies against the virus.

Scientists have evidence that monoclonal antibodies they developed may provide the ...